SATURDAY, Mar 31 (HealthDay News) A diabetes remedy used
by millions is now display guarantee opposite a accumulation of opposite cancers.
Two new clinical studies to be presented Saturday during a annual meeting
of a American Association for Cancer Research, in Chicago, found that
metformin (also famous by a code name Glucophage, among others),
appeared related to a negligence in a rate of prostate cancer expansion in
certain patients, and in prolonging life for early-stage pancreatic cancer
patients.
Other studies, finished possibly in a lab or in animals, also spirit that the
drug competence have an outcome opposite liver or verbal tumors, as good as certain
forms of melanoma.
The commentary have sparked seductiveness in a cancer margin and do seem
promising, though many some-more investigate needs to be finished before a drug can be
recommended as a cancer treatment, experts said.
There are really sparkling clues from laboratory studies and population
studies that metfo...
0 comments
Post a Comment